12.2. Drugs acting on the nose
12.2.1. Drugs used in nasal allergy
Restrictions:
For use in patients who require both a nasal steroid and nasal antihistamine and where compliance is considered to be an issue.
Prescribing Notes:
Patient should have tried monotherapy with a nasal steroid for 6-12 weeks first with no benefit.
Restrictions:
Restricted to specialist initiation. Restricted to allergic rhinitis patients in whom beclomethasone and budesonide have been ineffective or not tolerated.
Restrictions:
Restricted to specialist initiation where fluticasone nasal sprays should be reserved for patients in whom beclometasone and budesonide have been ineffective or not tolerated. Flixotide Nasules® are not included in the GGC Formulary.
Prescribing Notes:
Mometasone nasal sprays should be reserved for patients for whom preferred list options have been ineffective or not tolerated.
Restrictions:
For use where monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient.
Prescribing Notes:
Patient should have tried monotherapy with a nasal steroid for 6-12 weeks first with no benefit.
12.2.2. Topical nasal decongestants
Prescribing Notes:
Available as 0.1% nasal drops and a 0.1% nasal spray. Maximum duration for treatment is 7 days as further use can cause rebound congestion.